Jason A. Campagna
Hoofd Techniek/Wetenschap/O&O bij Q32 Bio, Inc.
Vermogen: - $ op 30-04-2024
Actieve functies van Jason A. Campagna
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Hoofd Techniek/Wetenschap/O&O | - | - |
Loopbaan van Jason A. Campagna
Eerdere bekende functies van Jason A. Campagna
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
PLANTABLE HEALTH INC. | Directeur/Bestuurslid | 26-11-2021 | 31-03-2023 |
Independent Dir/Board Member | 26-11-2021 | 31-03-2023 | |
INTERCEPT PHARMACEUTICALS, INC. | Hoofd Techniek/Wetenschap/O&O | 01-12-2019 | 05-03-2021 |
THE MEDICINES COMPANY | Corporate Officer/Principal | - | 01-08-2016 |
ProFibrix BV
ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Algemeen Directeur | - | - |
Annovation BioPharma, Inc.
Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Directeur/Bestuurslid | - | - |
Opleiding van Jason A. Campagna
University of Miami | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Nederland | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 3 |
Director/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 6 |
Consumer Services | 2 |
Retail Trade | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
PLANTABLE HEALTH INC. | Retail Trade |
Bedrijven in privébezit | 4 |
---|---|
Annovation BioPharma, Inc.
Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Annovation BioPharma, Inc. develops pharmaceutical products in the field of anesthesia, sedation and sleep. It is developing a rapid-acting anesthesia called Rapidate. The firm's novel agents are designed to allow more precise control of anesthesia and enable safer treatment of patients undergoing surgical procedures. The company was founded in 2009 by Nicholas Barker and is headquartered in Parsippany, NJ. | Health Technology |
The Medicines Co.
The Medicines Co. Pharmaceuticals: MajorHealth Technology The Medicines Co. is a biopharmaceutical company, which focuses on saving lives, alleviating suffering and contributing to the economics of healthcare by focusing on acute and intensive care hospitals worldwide. The firm markets its brands Angiomax, Cleviprex, injectable emulsion, Ionsys, Kengreal, Minocin for injection, and Orbactiv. The company was founded by Clive A. Meanwell, Helmut Giersiefen, John W. Villiger and T. Scott Johnson on July 31, 1996 and is headquartered in Parsippany, NJ. | Health Technology |
ProFibrix BV
ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Health Technology |
Q32 Bio, Inc.
Q32 Bio, Inc. BiotechnologyHealth Technology Q32 Bio Operations, Inc. develops immunomodulatory therapies with protein based molecules using a platform. The company was founded by Shelia Violette and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Jason A. Campagna
- Ervaring